Elevated risk of Parkinson’s disease among people with type 2 diabetes appears to be reduced by some medications used to treat their diabetes, finds a new study led by Professor Tom Foltynie (MyAV·¶ Queen Square Institute of Neurology) and Professor Li Wei (MyAV·¶ School of Pharmacy).
, ,ĚýMyAV·¶ News
Close
